Cite
Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.
MLA
Kim, Dong Hyun, et al. “Artificial Intelligence‐powered Spatial Analysis of Tumor‐infiltrating Lymphocytes as a Predictive Biomarker for Axitinib in Adenoid Cystic Carcinoma.” Head & Neck, vol. 45, no. 12, Dec. 2023, pp. 3086–95. EBSCOhost, https://doi.org/10.1002/hed.27537.
APA
Kim, D. H., Lim, Y., Ock, C., Park, G., Park, S., Song, H., Ma, M., Mostafavi, M., Kang, E. J., Ahn, M., Lee, K., Kwon, J. H., Yang, Y., Choi, Y. H., Kim, M. K., Ji, J. H., Yun, T., Kim, S., & Keam, B. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck, 45(12), 3086–3095. https://doi.org/10.1002/hed.27537
Chicago
Kim, Dong Hyun, Yoojoo Lim, Chan‐Young Ock, Gahee Park, Seonwook Park, Heon Song, Minuk Ma, et al. 2023. “Artificial Intelligence‐powered Spatial Analysis of Tumor‐infiltrating Lymphocytes as a Predictive Biomarker for Axitinib in Adenoid Cystic Carcinoma.” Head & Neck 45 (12): 3086–95. doi:10.1002/hed.27537.